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Faustin et al. (2007) generate another
set of important questions revolving
around the ‘‘inflammasome.’’ Although
certain murine polymorphisms in
Nalp1b appear to dictate the response
to anthrax lethal toxin, the involvement
of NALP1 in recognizing MDP in vitro
suggests that this protein is important
in the detection of a broad array of bac-
terial pathogens (Boyden and Dietrich,
2006). NOD2, another NLR family
member, appears to be essential for
the activation of NFkB in response to
MDP and has long been considered
a candidate as an intracellular MDP
sensor. The role of NALP1 in the phys-
iologic response to MDP in intact cells
or animals (i.e., the in vivo correlation
of the in vitro reconstitution) and the
identity of the MDP sensor in a physio-
logical setting remain major unre-
solved issues. Further, although cas-
pase-1 was previously demonstrated
to be active within a NALP1-containing
complex that includes other proteins,
Faustin et al. (2007) clearly demon-
strate that cleaved, active caspase-1
is generated in the presence of
NALP1 with the mere addition of MDP
and NTP. The cleaved caspase-1 may
represent active enzyme released
from the inflammasome by cleavage
of the regulatory CARD domain. Addi-
tion of purified caspase-5 and ASC
might clarify their roles. Finally, the
nucleotide-binding cycle, and its role
in NALP1-inflammasome assembly,
remain mysterious. NALP1 may be
empty or bound to either NTP or NDP
in the basal state (Figure 1). Depending
on the initial state of NALP1, MDP may
induce a nucleotide-binding-compe-
tent conformation, release of diphos-
phate nucleotide, or hydrolysis of
triphosphate nucleotide.
Though many questions remain re-
garding both the assembly of the
NALP1 inflammasome and the gener-
alizability of NALP1 activation to other
NLR proteins, Faustin and colleagues
have clearly laid out the viability of
using reconstitution of caspase-1
activation as a method to study host-
pathogen interactions.
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Restriction of both bacterial and viral pathogen growth by autophagy has been documented in vitro.
In this issue of Cell Host & Microbe, Orvedahl et al. demonstrate for the first time that inhibition of
autophagy by a viral gene product is essential for neurovirulence of herpesviruses.Autophagy constitutes, in addition to
proteasomal degradation, a second
major catabolic process for the turn-
over of cytoplasmic constituents of eu-
karyotic cells (Kim and Klionsky, 2000).
The biological process of autophagy is
comprised of at least three pathways,
macroautophagy, microautophagy,and chaperone-mediated autophagy.
Although autophagy has been initially
characterized as a cellular response
to nutrient starvation conditions, sev-
eral studies have recently implicated
macroautophagy in innate and adap-
tive immune resistance to pathogens
(Schmid et al., 2006). By now, 30 es-Cell Host & Microsential genes for this process have
been identified in yeast and higher
eukaryotes. They are involved in
assembling an isolation membrane
around a portion of cytoplasm at the
preautophagosomal structure (PAS),
completion of the double-membrane-
surrounded autophagosome, andbe 1, March 2007 ª2007 Elsevier Inc. 9
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PreviewsFigure 1. The Herpes Simplex Virus Protein ICP34.5 Interacts with Beclin-1 to Block
PKR-Dependent Macroautophagy Induction, which Limits Neurovirulence by HSV-1
See text for details.transport to and fusion with late endo-
somes for lysosomal degradation of
the cytoplasmic content and the inner
autophagosome membrane (Figure 1).
Innate resistance by macroautoph-
agy has most extensively been studied
in the context of bacterial pathogens.
Single-stranded RNA and double-
stranded DNA virus also seem to be
sensitive to induction of macroautoph-
agy by the host and subvert this pro-
cess to their benefit. Two main steps
in the autophagic process can be tar-
geted by viruses: the generation and
the degradation of autophagosomes.
The single-stranded RNA viruses
poliovirus and mouse hepatitis virus
seem to block the degradation of
autophagosomal membranes and use
them as scaffolds to anchor their
RNA replication complexes (Jackson
et al., 2005; Prentice et al., 2004).
Accumulation of autophagosomal
membrane structures are therefore a
hallmark of infection with these sin-
gle-stranded RNA viruses, and when
one interferes with autophagosomal
membrane assembly, virus replication
is compromised in infected cells.
During viral infections that cannot
make use of autophagosomal mem-
branes for their replication, the inhibi-
tion of autophagosome generation
seems beneficial for virus replication,
and the enhancement of this process
might provide a survival advantage to
the host. Indeed, the study by Orve-10 Cell Host & Microbe 1, March 2007 ª2dahl and colleagues (Orvedahl et al.,
2007) reported in this issue of Cell
Host & Microbe demonstrates an es-
sential role for autophagy inhibition
by a herpesviruses gene product
during neurovirulence in vivo.
The autophagy-related gene 6
(ATG6), called Beclin 1 in plants and
mammals, has emerged as a major ac-
tivator of autophagosome formation
(Figure 1), probably via its interaction
with the class III PI3 kinase complex,
which recruits other ATGs to the preau-
tophagosomal structure. Mouse Beclin
1 was identified as an interaction
partner of B cell lymphoma/leukemia-
2 gene product (BCL-2), conferring re-
sistance to neurovirulent Sindbis virus
infection (Liang et al., 1998). Similarly,
loss of Beclin 1 leads to increased rep-
lication of tobacco mosaic virus in
infected plants (Liu et al., 2005). In
contrast to these single-stranded
RNA viruses, double-stranded DNA
viruses with a more complex genome
have developed escape mechanisms
against macroautophagy by targeting
Beclin-1. The viral BCL-2 protein of
Kaposi’s sarcoma-associated g-her-
pesvirus (KSHV) interacts with the
N-terminal domain of Beclin-1 to inhibit
macroautophagy (Pattingreetal., 2005).
The a-herpesvirus herpes simplex
virus type 1 (HSV-1) has developed
a different strategy to target Beclin-1.
As reported by Orvedahl and col-
leagues, it carries the early antigen,007 Elsevier Inc.infected-cell protein 34.5 (ICP34.5),
which interacts with the C-terminal
domain of Beclin-1 to inhibit macroau-
tophagy (Figure 1) (Orvedahl et al.,
2007). Importantly, the ICP34.5 do-
main that binds to Beclin-1 (aa 68–87)
is not involved in ICP34.5’s inhibition
of the translational host cell shutoff,
but rather mediates a second viral es-
cape mechanism of this protein from
innate immune control. This viral
escape mechanism seems to be
essential for neurovirulence of HSV-1
in vivo, since recombinant HSV-1,
carrying an ICP34.5 mutant deficient
in the Beclin-1-binding domain (HSV-1
34.5D68–87), does not efficiently repli-
cate in the mouse central nervous
system (CNS) in vivo and fails to cause
fatal pathology after CNS infection
with HSV-1.
While this study represents the first
firm evidence that viral escape from
macroautophagy is essential for path-
ogenesis in vivo, it poses new, exciting
questions regarding both the induction
of macroautophagy in response to vi-
ral infection and the protective mecha-
nism against viral infection mediated
by macroautophagy. The study by
Orvedahl and colleagues demon-
strates that macroautophagy induc-
tion upon HSV-1 infection is depen-
dent on the double-stranded RNA
activated protein kinase R (PKR), and
that mutant HSV-1 34.5D68–87 re-
gains neurovirulence in pkr knockout
mice (Orvedahl et al., 2007). The sig-
nals leading to PKR-dependent mac-
roautophagy activation, which pro-
bably involves type I interferons and
pathogen pattern recognition recep-
tors, should be characterized in order
to explore macroautophagy’s poten-
tial for treatment of viral infections.
Interestingly, both virus infections in
mammals, for which a protective role
of macroautophagy has been impli-
cated, caused neuropathology; neuro-
virulence by Sindbis virus and HSV-1
was affected by inhibition of macroau-
tophagy (Liang et al., 1998; Orvedahl
et al., 2007). Therefore, the CNS might
rely on macroautophagy induction as
a mechanism to restrict viral replica-
tion and to resist infections. These
mechanisms of resistance to viral in-
fections via macroautophagy in vivo
should be explored further, as they
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tic targets in the CNS.
Apart from simple virion and viral
component sequestration and degra-
dation in the infected cell (Figure 1), it
has been recently shown that macro-
autophagy leads to efficient antigen
processing for MHC class II presenta-
tion to CD4+ T cells (Schmid et al.,
2007). Furthermore, macroautophagy
was demonstrated to deliver ligands
for pathogen pattern receptors to en-
dosomal compartments in plasmacy-
toid dendritic cells (Lee et al., 2007),
thereby activating both innate immune
mechanisms and adjuvant function of
these cells for adaptive immune re-
sponses during viral infection. There-
fore, macroautophagy induction dur-
ing viral infection might restrict virus
replication within infected cells, alarm
the innate immune system, and lead
to antigen presentation to the adaptive
immune system. The immune escape
mechanisms that viruses have devel-
oped to prevent this sequence ofevents, and that are beginning to be
uncovered, indicate strong evolution-
ary pressure to escape innate and
adaptive immune control via macro-
autophagy.
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